Put Options

24 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $230,000 - $252,890
500 New
500 $232,000
Q1 2024

May 14, 2024

SELL
$407.69 - $446.08 $733,842 - $802,944
-1,800 Reduced 51.43%
1,700 $710,000
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $68,600 - $82,136
-200 Reduced 5.41%
3,500 $1.42 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $574,906 - $616,182
1,700 Added 85.0%
3,700 $1.29 Million
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $282,978 - $316,719
-900 Reduced 31.03%
2,000 $703,000
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $2.01 Million - $2.29 Million
-7,100 Reduced 71.0%
2,900 $913,000
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $771,552 - $867,996
2,700 Added 36.99%
10,000 $2.89 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $14.4 Million - $16.1 Million
-52,700 Reduced 87.83%
7,300 $2.11 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $12 Million - $14.9 Million
-51,100 Reduced 45.99%
60,000 $16.9 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $9.88 Million - $11.6 Million
-44,600 Reduced 28.64%
111,100 $29 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $3.27 Million - $4.13 Million
-18,500 Reduced 10.62%
155,700 $34.2 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $14 Million - $15.7 Million
77,100 Added 79.4%
174,200 $31.6 Million
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $4.46 Million - $5.26 Million
23,800 Added 32.47%
97,100 $19.6 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $25.4 Million - $29.6 Million
-122,600 Reduced 62.58%
73,300 $15.8 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $24.3 Million - $32.4 Million
117,300 Added 149.24%
195,900 $46.3 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $2.86 Million - $3.39 Million
-11,200 Reduced 12.47%
78,600 $21.4 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $4.26 Million - $5.59 Million
18,900 Added 26.66%
89,800 $26.1 Million
Q1 2020

May 14, 2020

SELL
$199.77 - $247.81 $4.95 Million - $6.15 Million
-24,800 Reduced 25.91%
70,900 $16.9 Million
Q4 2019

Feb 13, 2020

SELL
$166.71 - $223.91 $11.5 Million - $15.4 Million
-68,800 Reduced 41.82%
95,700 $21 Million
Q3 2019

Nov 08, 2019

BUY
$166.23 - $187.09 $9.26 Million - $10.4 Million
55,700 Added 51.19%
164,500 $27.9 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $3.8 Million - $4.4 Million
23,100 Added 26.95%
108,800 $20 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $7.97 Million - $9.48 Million
48,700 Added 131.62%
85,700 $15.8 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $91,146 - $115,326
600 Added 1.65%
37,000 $6.13 Million
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $6.11 Million - $7.02 Million
36,400 New
36,400 $7.02 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.